Shanna Babalonis

Summary

Affiliation: University of Kentucky
Country: USA

Publications

  1. pmc Modulation of the discriminative stimulus effects of triazolam across the menstrual cycle phase in healthy pre-menopausal women
    Shanna Babalonis
    Department of Behavioral Science, University of Kentucky, Lexington, KY 40536 0086, USA
    Drug Alcohol Depend 94:276-80. 2008
  2. pmc Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers
    Shanna Babalonis
    University of Kentucky, Department of Behavioral Science, Center on Drug and Alcohol Research, Lexington, KY, USA Electronic address
    Drug Alcohol Depend 172:9-13. 2016
  3. pmc Abuse liability and reinforcing efficacy of oral tramadol in humans
    Shanna Babalonis
    University of Kentucky College of Medicine, Department of Behavioral Science, Lexington, KY 40536 0086, United States
    Drug Alcohol Depend 129:116-24. 2013
  4. pmc Physiological doses of progesterone potentiate the effects of triazolam in healthy, premenopausal women
    Shanna Babalonis
    Department of Behavioral Science, College of Medicine, University of Kentucky Medical Center, Lexington, KY 40536 0086, USA
    Psychopharmacology (Berl) 215:429-39. 2011
  5. pmc Progesterone effects on the discriminative stimulus, subjective and performance effects of triazolam in healthy, premenopausal women
    Shanna Babalonis
    Department of Behavioral Science, University of Kentucky Medical Center, Lexington, Kentucky, USA
    Behav Pharmacol 22:441-9. 2011
  6. pmc Comparison of the behavioral and cardiovascular effects of intranasal and oral d-amphetamine in healthy human subjects
    Joshua A Lile
    Department of Behavioral Science, Medical Behavioral Science Building, College of Medicine, University of Kentucky, Lexington, KY 40536 0086, USA
    J Clin Pharmacol 51:888-98. 2011
  7. pmc Intranasal buprenorphine alone and in combination with naloxone: Abuse liability and reinforcing efficacy in physically dependent opioid abusers
    Sharon L Walsh
    Center on Drug and Alcohol Research, University of Kentucky, 845 Angliana Avenue, Lexington, KY 40508, USA Department of Behavioral Science, University of Kentucky, USA Department of Psychiatry, University of Kentucky, USA Department of Pharmacology, University of Kentucky, USA Department of Pharmaceutical Sciences, University of Kentucky, USA Electronic address
    Drug Alcohol Depend 162:190-8. 2016
  8. pmc Pharmacodynamic effects of oral oxymorphone: abuse liability, analgesic profile and direct physiologic effects in humans
    Shanna Babalonis
    College of Medicine, Department of Behavioral Science, University of Kentucky, Lexington, USA
    Addict Biol 21:146-58. 2016
  9. pmc Opioid withdrawal suppression efficacy of oral dronabinol in opioid dependent humans
    Michelle R Lofwall
    University of Kentucky College of Medicine UK COM, Center on Drug and Alcohol Research, 845 Angliana Ave, Lexington, KY 40508, United States UK COM, Department of Behavioral Science, Lexington, KY 40536, United States UK COM, Department of Psychiatry, Lexington, KY 40509, United States
    Drug Alcohol Depend 164:143-50. 2016
  10. pmc Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: a two-phase randomized controlled trial
    Michelle R Lofwall
    University of Kentucky UK, Department of Psychiatry, Lexington, KY 40509, USA UK, Department of Behavioral Science, Lexington, KY 40502, USA UK, Center on Drug and Alcohol Research, Lexington, KY 40502, USA Electronic address
    Drug Alcohol Depend 133:188-97. 2013

Detail Information

Publications14

  1. pmc Modulation of the discriminative stimulus effects of triazolam across the menstrual cycle phase in healthy pre-menopausal women
    Shanna Babalonis
    Department of Behavioral Science, University of Kentucky, Lexington, KY 40536 0086, USA
    Drug Alcohol Depend 94:276-80. 2008
    ..These results suggest that the discriminative stimulus effects of the positive GABA(A) modulator, triazolam, are sensitive to menstrual cycle phase in healthy adult women...
  2. pmc Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers
    Shanna Babalonis
    University of Kentucky, Department of Behavioral Science, Center on Drug and Alcohol Research, Lexington, KY, USA Electronic address
    Drug Alcohol Depend 172:9-13. 2016
    ..g., pain, epilepsy, cancer, various drug dependencies). However, CBD remains a Schedule I drug on the U.S. Controlled Substances Act (CSA). Despite its status, there are no well-controlled data available regarding its abuse liability...
  3. pmc Abuse liability and reinforcing efficacy of oral tramadol in humans
    Shanna Babalonis
    University of Kentucky College of Medicine, Department of Behavioral Science, Lexington, KY 40536 0086, United States
    Drug Alcohol Depend 129:116-24. 2013
    ..The purpose of this study was to examine the relative abuse liability and reinforcing efficacy of tramadol in comparison to a high (oxycodone) and low efficacy (codeine) opioid agonist...
  4. pmc Physiological doses of progesterone potentiate the effects of triazolam in healthy, premenopausal women
    Shanna Babalonis
    Department of Behavioral Science, College of Medicine, University of Kentucky Medical Center, Lexington, KY 40536 0086, USA
    Psychopharmacology (Berl) 215:429-39. 2011
    ....
  5. pmc Progesterone effects on the discriminative stimulus, subjective and performance effects of triazolam in healthy, premenopausal women
    Shanna Babalonis
    Department of Behavioral Science, University of Kentucky Medical Center, Lexington, Kentucky, USA
    Behav Pharmacol 22:441-9. 2011
    ..Additional research is necessary to determine the degree to which neurosteroids influence sex differences in benzodiazepine use and abuse...
  6. pmc Comparison of the behavioral and cardiovascular effects of intranasal and oral d-amphetamine in healthy human subjects
    Joshua A Lile
    Department of Behavioral Science, Medical Behavioral Science Building, College of Medicine, University of Kentucky, Lexington, KY 40536 0086, USA
    J Clin Pharmacol 51:888-98. 2011
    ....
  7. pmc Intranasal buprenorphine alone and in combination with naloxone: Abuse liability and reinforcing efficacy in physically dependent opioid abusers
    Sharon L Walsh
    Center on Drug and Alcohol Research, University of Kentucky, 845 Angliana Avenue, Lexington, KY 40508, USA Department of Behavioral Science, University of Kentucky, USA Department of Psychiatry, University of Kentucky, USA Department of Pharmacology, University of Kentucky, USA Department of Pharmaceutical Sciences, University of Kentucky, USA Electronic address
    Drug Alcohol Depend 162:190-8. 2016
    ..This study sought to examine the relative abuse liability and reinforcing efficacy of intranasal buprenorphine compared to intranasal buprenorphine/naloxone in opioid-dependent individuals...
  8. pmc Pharmacodynamic effects of oral oxymorphone: abuse liability, analgesic profile and direct physiologic effects in humans
    Shanna Babalonis
    College of Medicine, Department of Behavioral Science, University of Kentucky, Lexington, USA
    Addict Biol 21:146-58. 2016
    ....
  9. pmc Opioid withdrawal suppression efficacy of oral dronabinol in opioid dependent humans
    Michelle R Lofwall
    University of Kentucky College of Medicine UK COM, Center on Drug and Alcohol Research, 845 Angliana Ave, Lexington, KY 40508, United States UK COM, Department of Behavioral Science, Lexington, KY 40536, United States UK COM, Department of Psychiatry, Lexington, KY 40509, United States
    Drug Alcohol Depend 164:143-50. 2016
    ..This proof-of-concept study examined the potential efficacy of a CB1 receptor partial agonist, dronabinol, in relieving signs and symptoms of opioid withdrawal...
  10. pmc Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: a two-phase randomized controlled trial
    Michelle R Lofwall
    University of Kentucky UK, Department of Psychiatry, Lexington, KY 40509, USA UK, Department of Behavioral Science, Lexington, KY 40502, USA UK, Center on Drug and Alcohol Research, Lexington, KY 40502, USA Electronic address
    Drug Alcohol Depend 133:188-97. 2013
    ..The purpose of this study was to evaluate: (1) the efficacy of extended-release (ER) tramadol in treating prescription opioid withdrawal and (2) whether cessation of ER tramadol produces opioid withdrawal...
  11. pmc Evaluation of estradiol administration on the discriminative-stimulus and subject-rated effects of d-amphetamine in healthy pre-menopausal women
    Joshua A Lile
    University of Kentucky Medical Center, Department of Behavioral Science, College of Medicine, Lexington 40536 0086, United States
    Pharmacol Biochem Behav 87:258-66. 2007
    ..These findings provide limited support for the notion that estradiol increases sensitivity to the psychostimulant effects of drugs such as d-amphetamine...
  12. pmc Safety of oral dronabinol during opioid withdrawal in humans
    Crystal J Jicha
    University of Kentucky College of Medicine UK COM, Center on Drug and Alcohol Research, 845 Angliana Ave, Lexington, KY 40508, United States Electronic address
    Drug Alcohol Depend 157:179-83. 2015
    ..Dronabinol, a cannabinoid (CB) 1 receptor agonist, is currently under investigation as a novel opioid withdrawal treatment. This study reports on safety outcomes of dronabinol among adults in opioid withdrawal...
  13. pmc Quinine as a potential tracer for medication adherence: A pharmacokinetic and pharmacodynamic assessment of quinine alone and in combination with oxycodone in humans
    Shanna Babalonis
    University of Kentucky College of Medicine, Department of Behavioral Science, Lexington, KY, USA
    J Clin Pharmacol 55:1332-43. 2015
    ..Overall, low-dose quinine appears to be a good candidate for a medication additive to monitor adherence for detection of missed medication...
  14. ncbi The Abuse Potential of Prescription Opioids in Humans-Closing in on the First Century of Research
    Sharon L Walsh
    Department of Behavioral Science, Center on Drug and Alcohol Research, University of Kentucky, Lexington, USA
    Curr Top Behav Neurosci . 2016
    ..Finally, the prescription opioid epidemic beginning in the 1990's in the US led to a resurgence in abuse potential evaluations, and the application of these methods to the study of novel abuse-deterrent formulations is discussed...

Research Grants1

  1. Separate and Combined Effects of Progesterone and Triazolam in Healthy Women
    Shanna Babalonis; Fiscal Year: 2008
    ..As such, these studies will contribute towards the development of gender-specific intervention and/or prevention strategies and health management approaches. [unreadable] [unreadable] [unreadable]..